Tomasz Sewastianik

Director - Clinical Biomarker Development @Eli Lilly and Company

Boston, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Oct 2025 — Present

Director - Clinical Biomarker Development @Eli Lilly and Company

View department →

EDUCATION

2014 — 2015

Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Poland

Doctor of Philosophy - PhD, Medicine

2010 — 2011

Nencki Institute of Experimental Biology in Warsaw, Poland

Master's degree, Biotechnology

2011 — 2015

Institute of Hematology and Transfusion Medicine in Warsaw, Poland

Doctor of Philosophy - PhD, Medicine

2006 — 2009

Uniwersytet Marii Curie-Skłodowskiej w Lublinie

Bachelor's degree, Biotechnology

2009 — 2011

Uniwersytet Marii Curie-Skłodowskiej w Lublinie

Master's degree, Biotechnology

ABOUT TOMASZ SEWASTIANIK

Director at Eli Lilly and Company

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Tomasz Sewastianik — Director - Clinical Biomarker Development at Eli Lilly and Company in Boston, MA, US | Unifers